AI precision tumor medical platform Caris Life Sciences (CAI.US) raised 494 million US dollars on the first day of its listing on the US stock market, with a staggering 33% increase.

According to the Finance and Economics APP, medical technology company Caris Life Sciences (CAI.US) landed on the Nasdaq market on Wednesday, Eastern Time, raising $494 million in its initial public offering (IPO) in the US, with the issue price higher than the original upper limit. The stock surged nearly 40% as soon as it went public, closing up 33% at $28 on Wednesday.